The insulin-like growth factor-2 (Igf2)-H19 locus encodes important paternally imprinted genes that govern normal embryonic development. While Igf-2 encodes IGF2, which is an autocrine/paracrine mitogen, transcription of H19 gives rise to non-coding mRNA that is a precursor of several microRNAs (miRNAs) that negatively affect cell proliferation. The proper imprinting of a differentially methylated region (DMR) within this locus, with methylation of the paternal chromosome and a lack of methylation on the maternal chromosome, regulates expression of both of these genes so that Igf2 is transcribed only from the paternal chromosome and H19 only from the maternal chromosome. There is growing evidence that this 'Yin-Yang' locus regulates embryonic development. Furthermore, recent evidence indicates that erasure of imprinting (hypomethylation) of the Igf2-H19 locus on both chromosomes, which leads to downregulation of Igf2 and upregulation of H19 expression, plays an important role in regulating quiescence of pluripotent stem cells in adult organisms, and may be involved in the regulation of lifespan. In contrast, hypermethylation of this locus on both chromosomes (loss of imprinting) results in Igf2 overexpression and is observed in several malignancies. In this review, we will discuss the biological consequences of changes in
Introduction
Mammalian development requires proper gene dosage, which is enabled by the imprinting of genes so that a single parental allele is expressed. In other words, genomic imprinting is an epigenetic program that ensures the parent-of-origin-specific monoallelic transcription of imprinted genes and results in intracellular expression of imprinted genes from only one of the two paternal chromosomes, derived either from the mother or the father [1] [2] [3] [4] [5] .
Overall, there are ~100 paternally imprinted genes in the mammalian genome (expressed from the maternal or paternal chromosome only) that play an important role in embryonal development. Imprinted genes play a crucial role in embryogenesis, fetal growth, behavioral development, the totipotential state of the zygote, and pluripotency of developmentally early stem cells [4] . On the other hand, erasure of genomic imprints is one of the mechanisms that prevent some of the pluripotent stem cells (e.g. primordial germ cells [PGCs] and very small embryon- www.fhc.viamedica.pl ic-like stem cells [VSELs] ) from uncontrolled proliferation and teratoma formation [6] [7] [8] [9] [10] [11] [12] [13] .
The expression of imprinted genes is regulated by the imposition of epigenetic marks by DNA methylation within differentially methylated regions (DMRs), which are CpG-rich cis-elements within their loci [1] [2] [3] [4] . These epigenetic marks imposed on DMRs in the female germline act on the promoters of imprinted genes, which results in the heritable repression of the maternal chromosomes. In contrast, the imposition of epigenetic marks by methylation of the chromosomes in the male germline does not occur at the promoters, but rather within the intergenic regions (i.e. between the Igf2 and H19 genes). Imprinted genes, in general, are highly expressed during embryogenesis, and many of them are subsequently downregulated after birth. Most imprinted genes are methylated on maternally derived chromosomes, and only four: Igf2-H19, RasGrf1, Dlk1/Dio3, and Zdbf2, are methylated on paternally derived chromosomes [1] [2] [3] [4] . In this review, we will focus on the biological consequences of imprinting within the DMR for Igf2-H19.
The Igf2-H19 tandem gene is paternally imprinted in humans as well as in mice and, as mentioned above, the regulatory DMR for this gene is methylated on the paternal, and erased on the maternal, chromosome [1] [2] [3] [4] . Figure 1 shows a schematically simplified structure for this locus. The filled lollypops at the DMR regulatory region of the paternal chromosome depict methylation, and open lollypops on the maternal chromosome indicate lack of methylation. If the DMR is methylated, it cannot bind the regulatory DNA-binding zinc finger insulator protein, CTCF, which establishes a functional boundary between the Igf2 and H19 coding regions. The binding of CTCF has immediate consequences for the expression of these loci. Since the expression of both Igf2 and H19 is regulated from a 3' distal enhancer (shown as a green box), the presence of CTCF bound to the DMR at the maternal locus prevents transcription of Igf2, and in this situation, only H19 is transcribed to RNA. In contrast, the presence of a methylated DMR on the paternal chromosome prevents binding of CTCF, and in this situation, the 3' distal enhancer promotes transcription of mRNA from the Igf2 locus. This ensures a proper balance in the expression of both genes ( Figure 2, upper panel) .
As discussed in this review, the methylation of DMRs within the Igf2-H19 locus is erased in pluripotent stem cells, such as PGCs [6] [7] [8] [9] [10] [11] and VSELs [12, 13] (Figure 2 , middle panel). This epigenetic modification of Igf2-H19 is one of the mechanisms responsible for keeping these cells quiescent (low expression of Igf2 and overexpression of H19) and prevents them from uncontrolled proliferation and teratoma formation. In contrast, hypermethylation of DMRs within Igf2-H19 on both maternally and paternally derived chromosomes, which is called 'loss of imprinting', is observed in several malignancies and results in high expression of Igf2 (Figure 2, lower panel) . Loss of imprinting at this locus, as will be discussed later, could also result from perturbation of other mechanisms that regulate the proper Igf2:H19 expression ratio in these cells (e.g.downregulation of CTCF expression) [14] .
In this review, we will discuss the three possibilities (normal somatic imprinting, erasure of imprinting, and loss of imprinting) as epigenetic changes in methylation of DMRs for the Igf2-H19 'master locus' that affect several biological processes, such as proper embryogenesis, proliferation of pluripotent stem cells, senescence, and tumorogenesis.
Biological role of proper somatic imprinting of the Igf2-H19 tandem gene
The tandem Igf2-H19 locus is located on chromosome 11p15 in humans and chromosome 7 in mice. While the Igf2 locus encodes insulin-like growth factor-2 (IGF2), which is a growth-promoting peptide hormone highly expressed during embryogenesis, the H19 locus encodes a non-coding RNA (ncRNA) that gives rise to several microRNAs (miRNAs) that have opposite effects on cell proliferation [15] . The dual YinYang function of this master locus is relevant to several biological functions, including normal fetal development, and the properly balanced expression of Igf2 and H19 is crucial for proper embryogenesis (Figure 2 upper panel) . Imprinting at the Igf2-H19 locus is one of the major factors preventing parthenogenetic development in mammals, and the biological importance of this locus is demonstrated by the additional steps necessary for the creation of viable bimaternal mice derived from two female sets of chromosomes [1] [2] [3] [4] . These mice are created by combining two haploid nuclei, one from non-growing and the other from fully growing oocytes, into a diploid 'bimaternal zygote'. Since female chromosomes have unmethylated DMRs for Igf2-H19 (Figure 1 ), the crucial step is appropriate genetic modulation of the proper expression of Igf2 from one of the maternally derived sets of chromosomes [6] [7] [8] [9] [10] [11] [12] [13] .
The role of imprinted genes in development, including the master tandem gene Igf2-H19, has been explained by the parent-offspring conflict hypothesis. While during pregnancy, the father, through proper expression of paternally imprinted genes (i.e. by expression of Igf2 and suppression of H19), contrib- www.fhc.viamedica.pl utes to body size and muscle mass of the developing fetus, and wants the mother to devote as much of her resources as possible towards the growth of his offspring, the mother wants to conserve as much of her resources as possible towards future births (without compromising the health of the fetus she is carrying) by epigenetic modulation of genes by maternal imprinting marks (i.e. to achieve suppression of Igf2 and expression of H19) [4] . It is well known that IGF2 is secreted from cells in an autocrine or paracrine manner and exerts its biological effects after binding to the insulin-like growth factor-1 (IGF1) receptor (IGF-1R). On the other hand, IGF2 may also bind to non-signaling insulin--like growth factor-2 receptor (IGF-2R), which is a mannose 6-phosphate receptor that acts as a decoy receptor for IGF2 and prevents its signaling through IGF-1R [17] . Overall, the IGF2 level is high in humans during embryogenesis and in postnatal life may be produced and secreted by some tumors, causing their proliferation and hypoglycemia as part of the paraneoplastic syndrome. The loss of imprinting at the Igf2-H19 locus (Figure 1 , middle panel) leads to overexpression of Igf2, which is observed in Beckwith--Wiedemann syndrome and is associated with organomegaly of newborns and a high incidence of several pediatric sarcomas (e.g. rhabdomyosarcoma and nephroblastoma) [18, 19] .
In contrast, H19, as mentioned above, is a long, 2.3-kb, non-coding RNA (ncRNA) transcribed from the maternally inherited allele only; it is highly expressed prenatally and downregulated postnatally. It is well known that H19 ncRNA, which is evolutionarily conserved at the nucleotide level in humans and rodents and not translated to protein, is processed into small miRNAs [15] . This is supported by the finding that in situ hybridization of the H19 ncRNA revealed that it is detectable in cytoplasmic ribonucleoprotein particles, which suggests that H19-derived miRNAs are involved in ribosomal function and translation. However, the loss of H19 is not lethal in mice, http://en.wikipedia.org/wiki/H19_(gene) and such animals display an overgrowth phenotype similar to babies with Beckwith-Wiedemann syndrome, while the overexpression of H19 is a dominant lethal mutation; mouse embryos overexpressing H19 die after embryonic day 14.
The close coupling of Igf2 and H19 expression is explained by the fact that these two genes share the same 3' gene enhancer (Figure 1 ). It has been reported that deletion of this 3' enhancer results in downregulation of both Igf2 and H19 expression. Furthermore, there are some indications that the 3' enhancer has a more robust effect on the expression of H19 than Igf2. This could be explained by the facts that: 1) H19 has a stronger promoter than Igf2 [4, 14] ; and 2) that the H19 gene is physically closer to the 3' enhancer than Igf2 (Figures 1 and 2) .
The expression of Igf2-H19 is regulated from the 3' enhancer by the transcriptional zinc finger DNA--binding protein repressor, CTCF (also known as CCCTC-DNA sequence binding factor). The human genome contains nearly 15,000 CTCF insulator sites, suggesting a widespread role of CTCF in gene regulation [5, 14, 16] . What is of importance for this review is that this DNA-binding regulatory protein is involved in insulator activity for Igf2 expression by binding to the DMR at the Igf2-H19 locus (Figure 1) . Binding to the methylation-free DMR by CTCF blocks the interaction between the 3' distal enhancer and the promoter of Igf2, while not affecting H19 expression. Overall, four CTCF binding sites have been identified in the murine Igf2-H19 DMR and seven in the human counterpart. Interestingly, the human Igf2-H19 DMR is not able to function when introduced as a transgene into the murine genome, which suggests differences in the regulation of this DMR between species [14] .
In conclusion, proper imprinting of the Igf2-H19 locus is required for the balanced expression of both genes in somatic cells and in normal embryonic development.
Biological consequences of erasure of imprinting at the DMR for the Igf2-H19 tandem gene in primordial germ cells (PGCs)
The erasure of methylation in the DMR for Igf2-H19 (Figure 2 , middle panel) leads to downregulation of growth-promoting Igf2 from both paternal and maternal chromosomes and overexpression of proliferation-limiting H19. Therefore, cells that undergo such epigenetic modification tend to remain in a quiescent state, and this occurs early in the development of PGCs [6] [7] [8] [9] [10] [11] . Accordingly, PGCs, while they migrate during embryogenesis through the embryo proper into the genital ridges, erase several maternally and paternally imprinted loci, including the Igf2-H19 locus. This mechanism of erasure of imprinted marks has several important consequences. First, it prevents these cells from uncontrolled proliferation and the potential risk of teratoma formation. Second, it creates in mammals a barrier against parthenogenetic development [4] .
Furthermore, after the erasure of imprinting, PGCs are not able to proliferate in vitro and do not complement blastocyst development, while nuclei harvested from PGCs are not capable of performing as DNA donors in therapeutic cloning. However, all www.fhc.viamedica.pl these limitations in the pluripotency of PGCs are reversed when their imprinting is re-established during ex vivo generation from PGCs of embryonic germ cells (EGCs) [6] [7] [8] [9] [10] [11] .
During normal development, proper imprinting in germ line cells is established in later stages when PGCs, after colonization of the genital ridges, develop into gametes -oocytes or sperm. Proper imprinting is established in female germ line (paternal imprinting) and male germ line (maternal imprinting) cells after a first meiotic division when the chromosomes are reduced to haploid number. Thus, when haploid gametes fuse during fertilization, the chromosomes in the diploid zygote have proper imprinting, including at the Igf2-H19 loci.
As mentioned above, the importance of proper imprinting of Igf2-H19 during embryogenesis has also been demonstrated during generation of viable bimaternal mice [20] . The bimaternal zygote is generated from two female sets of chromosomes without participation of a paternal genome by combining two haploid nuclei from non-growing oocytes -one derived from a newborn pup and another from a fully grown oocyte. Since female chromosomes have unmethylated DMRs for Igf2-H19, the proper expression of Igf2 and H19 in this mouse was achieved by appropriate genetic modification of the Igf2-H19 locus on one set of female chromosomes to ensure that this locus expresses Igf2 [20] . [23, 24] . We hypothesize that these PSCs, which are called VSELs, are deposited in adult tissues, including during early embryogenesis, and serve as a backup for tissue-committed stem cells (TCSCs). Molecular analysis of VSELs has revealed that their quiescence in adult BM and premature depletion from the tissues is controlled by epigenetic changes to imprinted genes, including the Igf2-H19 locus, which is erased in murine VSELs [12, 13] (Figure 2, middle panel) .
Biological consequences of erasure of imprinting in the DMR of the Igf2-H19 tandem gene in very small embryonic-like stem cells (VSELs)
Murine VSELs, in addition to erasure at the Igf2-H19 locus, also modify expression of other imprinted genes. For example, we observed that murine BM-sorted VSELs erase the paternally methylated imprints (e.g. DMRs at the Igf2-H19 and RasGrf1 loci, Figure 3 ), while they hypermethylate the maternally methylated imprints (e.g. DMRs at Igf2R). The epigenetic modification of imprinted loci (including Igf2-H19) prevents VSELs from uncontrolled proliferation and, as in the case of PGCs, prevents them from teratoma formation. The epigenetic modification of imprinted genes also explains why VSELs, despite expressing several markers of pluripotency (e.g. open chromatin structure at the promoters for Oct-4 and Nanog), the presence of bivalent domains at developmentally important homeobox-domain containing genes, the reactivation of the X chromosome in female VSELs, and in vitro differentiation into cells from all three germ layers, do not complement blastocyst development after injection into the pre-implantation blastocyst [12, 13] .
There are also other important implications for erasure of paternally imprinted genes in VSELs. Namely, the erasure at the paternally imprinted Igf2-H19 and RasGrf1 loci leads to impair insulin/insulin-like growth factor signaling (IIS) in these cells [25] [26] [27] . This has a potential impact on the role of VSELs in tissue rejuvenation and aging as well as on the involvement of these cells in tumorogenesis.
Erasure of imprinting at the Igf2-H19 locus in VSELs and its implications for tissue rejuvenataion and aging
The abovementioned changes in expression of imprinted genes in VSELs lead to perturbation of IIS by downregulation of IGF2, which is an autocrine factor involved in proliferation of VSELs, and downregulation of RasGRF1, which is a GTP-exchange factor (GEF) crucial for signaling from IGF-IR and the insulin receptor (InsR, Figure 3 ). In addition, in VSELs we observed hypermethylation of DMRs on the maternal chromosome encoding IGF-2R [12, 13] , which, as mentioned above, serves as a decoy receptor that prevents IGF-2 from binding to IGF-IR [25] . Overall, this epigenetic reprogramming of genomic imprinting negatively affects IIS signaling, maintains the quiescent state of VSELs and thus protects them from premature depletion from the tissues, and prevents their involvement in tumor formation.
Based on these findings, we propose a novel hypothesis that relates aging, longevity, and IIS to the abun- www.fhc.viamedica.pl lifespan [25] [26] [27] [28] . In support of this expectation, we observed a significantly higher number of VSELs in long--living murine strains (e.g. Laron dwarfs and Ames dwarfs) whose longevity is explained by low levels of circulating IGF1 [29] [30] [31] [32] . In contrast, the number of VSELs is reduced compared to normally aging littermates in mice with high levels of circulating IGF1 (e.g. growth hormone-overexpressing transgenic mice) [32] .
Attempting to summarize all of this, the influence of IIS on the pool of VSELs residing in adult tissues seems to be twofold (Figure 4 ). In the first scenario, IGF2 is an autocrine factor for these cells, explaining why both downregulation of expression of Igf2 and RasGrf1 together with elevated expression of H19 and upregulation of IGF-2R, which is a decoy receptor for IGF2, keeps these cells quiescent. However, we observed that with increasing age, the methylation pattern of DMRs at paternally imprinted genes in VSELs reverses and Igf2-H19, as well as RasGrf1 loci, become gradually methylated, and thus VSELs become more sensitive to IIS [26] [27] [28] . This phenomenon may contribute to their age-related depletion over time.
On the other hand (second scenario), VSELs express functional IGF-1R and InsR and are susceptible to exogenous circulating IGF1 and insulin (Ins). Therefore, a chronic increase in caloric uptake that elevates circulating levels of these hormones may contribute over time to the depletion of these cells from adult tissues, affect the generation of VSEL-derived TCSCs, and thus negatively affect lifespan. In support of this scenario, we demonstrated that mice that have high levels of circulating blood plasma IGF1 show accelerated depletion of VSELs and have a shorter lifespan than age-matched littermates.
Erasure of imprinting at the Igf2-H19 locus in VSELs and its potential role in cancerogenesis
The changes in imprinting of the Igf2-H19 locus may be involved in tumor formation. A growing body of evidence suggests that cancer originates in the stem/ /progenitor cell compartment. This stem-cell-origin--of-cancer hypothesis is based on the assumption that self-renewing stem cells residing in organs and tissues, and not mature differentiated somatic cells such as those lining the bronchial or stomach mucosa, may accumulate mutations over a lifetime [33, 34] . These mutations are subsequently maintained in stem cell compartments, and self-renewing stem cells may be subjected to additional mutations and epigenetic changes so that the genome is destabilized and uncontrolled neoplastic proliferation is initiated.
Interestingly, during the 19 th and early 20 th centuries, several investigators proposed that cancer de- [34] . This 'embryonic rest' hypothesis of cancer origin suggested that adult tissues contain embryonic remnants that normally lie dormant, but can be activated to become cancerous. Based on the presence of VSELs in adult tissues, we hypothesize that VSELs could be the missing link that reconciles the embryonic rest hypothesis of cancer origin with current theories envisioning cancer as a stem cell disorder.
In support of this perspective, it is well known that obesity and high caloric uptake are risk factors for cancer development. Experimental animals with high levels of circulating IGF1 are not only short-lived but also have a high incidence of cancer [35] . On the other hand, long-living animals with low levels of circulating IGF2 have a much lower incidence of tumor growth [32] . This correlates with human Laron dwarfs that have a very low level of circulating IGF1 and at the same time are prone to cancer development [29, 32] . Based on these observations, we envision that chronic stimulation of VSELs by IIS may activate these cells in an uncontrolled way and promote their malignant growth. Therefore, it is likely that some human tumors originate in VSELs, and that IIS may play an important initiating role. Again, we envision here two possible mechanisms. Firstly VSELs exposed to a constant high circulating IGF1 level could transform into neoplastic cells; and secondly, as discussed below, they could transform due to a loss of imprinting at the Igf2-H19 locus that will expose them to autocrine IGF2.
Consequences for tumorogenisis of the loss of imprinting at the DMR for the Igf2-H19 tandem gene
There is growing evidence that the autocrine IGF2--IGF-1R loop, due to loss of imprinting at the Igf2-H19 locus (Figure 2, lower panel) , may be involved . This leads to an age-mediated VSEL depletion, and as a consequence a decrease in VSEL-generated tissue--committed stem cells (TCSCs), and impairs tissue organ rejuvenation. Right panel -VSELs deposited in adult tissues may, over time, become depleted more quickly by chronic elevated circulating levels of IGF1 and insulin that engage IGF1R and InsR expressed by these cells. This may contribute to accelerated aging observed in situations with high circulating IGF1 and insulin level (e.g. high calorie uptake). On other hand, this mechanism of chronic exposure to IIS may also lead to malignant transformation of VSELs after prolonged stimulation by IGF1 and insulin. For the sake of simplicity, two other proteins encoded by imprinted genes that affect IIS are not shown -paternally imprinted RasGrf1, which due to erasure of imprinting is not expressed in VSELs, and maternally imprinted IGF-2R, which due to hypermethylation of the DMR locus on the maternal chromosome, is highly expressed in these cells. While RasGRF1 is an important component of IIS from activated IGF-1R and InsR, IGF-2R serves as a decoy receptor for IGF2. Therefore, changes in expression of these genes in VSELs further decrease the responsiveness of these cells to IIS www.fhc.viamedica.pl in the growth of several types of tumors. The best example, as mentioned above, is Beckwith-Wiedemann syndrome, which is associated with the development of several pediatric sarcomas. The loss of imprinting at the Igf2-H19 locus is a very well-known phenomenon observed both in Beckwith-Wiedemann syndrome-related and spontaneous human rhabdomyosarcomas and nephroblastomas. Loss of imprinting at this locus has also been described in gastrointestinal tumors, both in humans and in mice [36] [37] [38] [39] . Furthermore, as mentioned above, one of the features of aging VSELs is gradual hypermethylation of DMRs for Igf2-H19 locus on the maternal chromosome that due to this 'age-related' loss of imprint leads to overexpression of IGF2 [26] [27] [28] . This may correspond to a higher incidence of cancer in advanced age. The deregulation of the Igf2-H19 locus observed in several tumors raises the question of the cell of origin in which this genetic defect originates. As discussed above, one possibility is that this event occurs in VSELs [33, 34] . This hypothesis, however, requires further studies.
Conclusions
Evidence has accumulated that the imprinted Igf2-H19 tandem gene plays a pleiotropic role in several biological processes. Expression of this locus is tightly regulated by genomic imprinting and the CTCF protein, which is involved in the balanced expression of both genes from either paternal or maternal chromosomes. In addition, an interesting mechanism has been described in which elevated levels of IGF2 in senescent human epithelial cells are the result of a reduction in CTCF expression, which controls the Igf2-H19 locus. As reported, an increase in the intracellular CTCF level, leading to lower occupancy of DMRs by CTCF within Igf-H19 loci, resulted in a 10-fold increase in intracellular Igf2 expression [14] .
Furthermore, it is likely that, in addition to CTCF, other proteins are also involved in the regulation of this locus and that they still await identification. Modification of expression at the Igf2-H19 locus may have an important role in inhibiting aging processes and preventing cancerogenesis. Furthermore, as we envision, proper methylation of the DMR at this locus, which is erased in VSELs [12, 13] , will be crucial for the development of ex vivo strategies for the expansion of VSELs for the purposes of regenerative medicine [40] .
